World FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis – Contract Pharma Last updated: April 14, 2026 9:31 pm Editorial Staff 7 months ago Share SHARE FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis Contract Pharmasource Live updates: Iran warns of 'strong responses' as Israel's attacks on Lebanon threaten ceasefire – NBC News Vietnam, Canada agree on economic cooperation direction for new period – en.qdnd.vn Boy dies after being shot in El Mirage neighborhood; suspect on the loose – AZ Family US launches new wave of strikes on Iran – nhk.or.jp Israel says it killed the leader of Hamas’ military wing, one of the architects of Oct. 7 attacks – KSAT Share This Article Facebook Email Print Previous Article Trump again rejects Colorado amid accusations of playing politics with disaster aid – Newsday Next Article Times Opinion: Vaccine confusion sets up US for a resurgence of hepatitis B in babies – Chattanooga Times Free Press Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
